SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549

                                    FORM 8-K

                 Current Report Pursuant to Section 13 or 15(d)
                     of the Securities Exchange Act of 1934

Date of Report:  January 8, 2003



                             HEALTHSOUTH Corporation
                          -----------------------------
             (Exact Name of Registrant as Specified in its Charter)


          Delaware                    1-10315                   63-0860407
        -------------               -----------                -------------
        State or Other              (Commission               (I.R.S. Employer
 Jurisdiction of Incorporation      File Number)             Identification No.)
      or Organization)


   One HEALTHSOUTH Parkway
     Birmingham, Alabama                                           35243
 ---------------------------                                     ---------
    (Address of Principal                                        (Zip Code)
      Executive Offices)


 Registrant's Telephone Number,
     Including Area Code:                                      (205) 967-7116







Item 9.  REGULATION FD DISCLOSURE

         On January 8, 2003, representatives of HEALTHSOUTH Corporation will
begin making presentations at investor conferences and other investor meetings
using slides containing the information attached to this Form 8-K as Exhibit 99.
We expect to use these slides, in whole or in part and possibly with
modifications, in connection with presentations to investors, analysts and
others during the first quarter of 2003. We are furnishing the text of these
slides pursuant to the Securities and Exchange Commission's Regulation FD. This
information is furnished pursuant to Item 9 of Form 8-K and shall not be deemed
to be "filed" for the purposes of Section 18 of the Securities Exchange Act of
1934 or otherwise subject to the liabilities of that Section, unless we
specifically incorporate it by reference in a document filed under the
Securities Act of 1933 or the Securities Exchange Act of 1934. By filing this
report on Form 8-K and furnishing this information, we make no admission as to
the materiality of any information in this report that is required to be
disclosed solely by reason of Regulation FD.

         The information contained in the slides is summary information that is
intended to be considered in the context of our SEC filings and other public
announcements that we may make, by press release or otherwise, from time to
time. We undertake no duty or obligation to publicly update or revise the
information contained in this report, although we may do so from time to time as
our management believes is warranted. Any such updating may be made through the
filing of other reports or documents with the SEC, through press releases or
through other public disclosure.

         The text of the slides included with this report omits various graphic
images included in the actual slides. We expect to make copies of the actual
slides, including such graphic images, available for viewing at the "Investor
Relations" section of our website located at www.healthsouth.com, although we
reserve the right to discontinue that availability at any time.

         Some of the matters discussed in this report (including its exhibit)
may constitute forward-looking statements. Some of these forward-looking
statements can be identified by the use of forward-looking terminology such as
"believes", "expects", "may", "will", "should", "seeks", "approximately",
"intends", "plans", "estimates" or "anticipates" or the negative thereof or
other comparable terminology, or by discussions of strategy, plans or
intentions. Without limiting the generality of the preceding statement, all
statements in this report concerning or relating to estimated and projected
earnings, margins, costs, expenditures, cash flows, growth rates and financial
results are forward-looking statements. In addition, we, through our senior
management, from time to time make forward-looking public statements concerning
our expected future operations and performance and other developments. These
forward-looking statements are necessarily estimates that we believe are
reasonable based on current information and involve a number of risks and
uncertainties. There can be no assurance that our actual results will not differ
materially from the results anticipated in such forward-looking statements.
While it is impossible to identify all such factors, factors which could cause
actual results to differ materially from those estimated by us include, but are
not limited to, changes in the regulation of the healthcare industry at either
or both of the federal and state levels, changes or delays in reimbursement for
our services by governmental or private payors, changes to or delays in the
implementation of the prospective payment system for inpatient rehabilitation
services, competitive pressures in the healthcare industry and our response
thereto, our ability to obtain and retain favorable arrangements with
third-party payors, unanticipated delays in the implementation of our strategic
plans, general conditions in the economy and capital markets and other factors
which may be identified from time to time in our SEC filings and other public
announcements.






Item 7.  FINANCIAL STATEMENTS AND EXHIBITS

      (c)   Exhibits

            99. Text of Investor Relations Slideshow In Use Beginning January 8,
2003.





                                   SIGNATURES

         Pursuant to the requirements of the Securities Exchange Act of 1934,
the Registrant has duly caused this Report to be signed on its behalf by the
undersigned hereunto duly authorized.

Date:    January 8, 2002

                                   HEALTHSOUTH CORPORATION

                                   By          /s/  WILLIAM W. HORTON
                                       -----------------------------------------
                                                  William W. Horton
                                              Executive Vice President
                                                and Corporate Counsel